These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24171767)

  • 1. Nicotinamide phosphoribosyltransferase as a target in inflammation- related disorders.
    Montecucco F; Cea M; Cagnetta A; Damonte P; Nahimana A; Ballestrero A; Del Rio A; Bruzzone S; Nencioni A
    Curr Top Med Chem; 2013; 13(23):2930-8. PubMed ID: 24171767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experience.
    Montecucco F; Cea M; Bauer I; Soncini D; Caffa I; Lasigliè D; Nahimana A; Uccelli A; Bruzzone S; Nencioni A
    Curr Drug Targets; 2013 Jun; 14(6):637-43. PubMed ID: 23531116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD.
    Busso N; Karababa M; Nobile M; Rolaz A; Van Gool F; Galli M; Leo O; So A; De Smedt T
    PLoS One; 2008 May; 3(5):e2267. PubMed ID: 18493620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities.
    Chen H; Wang S; Zhang H; Nice EC; Huang C
    Expert Rev Anticancer Ther; 2016 Aug; 16(8):827-38. PubMed ID: 27186719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAMPT inhibitor and metabolite protect mouse brain from cryoinjury through distinct mechanisms.
    Zhang XQ; Lu JT; Jiang WX; Lu YB; Wu M; Wei EQ; Zhang WP; Tang C
    Neuroscience; 2015 Apr; 291():230-40. PubMed ID: 25684751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells.
    Tan B; Dong S; Shepard RL; Kays L; Roth KD; Geeganage S; Kuo MS; Zhao G
    J Biol Chem; 2015 Jun; 290(25):15812-15824. PubMed ID: 25944913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications.
    Tan B; Young DA; Lu ZH; Wang T; Meier TI; Shepard RL; Roth K; Zhai Y; Huss K; Kuo MS; Gillig J; Parthasarathy S; Burkholder TP; Smith MC; Geeganage S; Zhao G
    J Biol Chem; 2013 Feb; 288(5):3500-11. PubMed ID: 23239881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism.
    Burgos ES
    Curr Med Chem; 2011; 18(13):1947-61. PubMed ID: 21517777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of nicotinamide phosphoribosyltransferase enzymatic activity ameliorates lung damage induced by ischemia/reperfusion in rats.
    Wu GC; Liao WI; Wu SY; Pao HP; Tang SE; Li MH; Huang KL; Chu SJ
    Respir Res; 2017 Apr; 18(1):71. PubMed ID: 28438162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors.
    Galli U; Travelli C; Massarotti A; Fakhfouri G; Rahimian R; Tron GC; Genazzani AA
    J Med Chem; 2013 Aug; 56(16):6279-96. PubMed ID: 23679915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review.
    Gasparrini M; Giovannuzzi S; Nocentini A; Raffaelli N; Supuran CT
    Expert Opin Ther Pat; 2024 Jul; 34(7):565-582. PubMed ID: 38861278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of nicotinamide phosphoribosyltransferase and depletion of nicotinamide adenine dinucleotide contribute to arsenic trioxide suppression of oral squamous cell carcinoma.
    Wang XY; Wang JZ; Gao L; Zhang FY; Wang Q; Liu KJ; Xiang B
    Toxicol Appl Pharmacol; 2017 Sep; 331():54-61. PubMed ID: 28501332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction.
    Montecucco F; Bauer I; Braunersreuther V; Bruzzone S; Akhmedov A; Lüscher TF; Speer T; Poggi A; Mannino E; Pelli G; Galan K; Bertolotto M; Lenglet S; Garuti A; Montessuit C; Lerch R; Pellieux C; Vuilleumier N; Dallegri F; Mage J; Sebastian C; Mostoslavsky R; Gayet-Ageron A; Patrone F; Mach F; Nencioni A
    Antioxid Redox Signal; 2013 Feb; 18(6):630-41. PubMed ID: 22452634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAMPT inhibition reduces macrophage inflammation through the NAD+/PARP1 pathway to attenuate liver ischemia-reperfusion injury.
    Lu J; Wang M; Chen Y; Song H; Wen D; Tu J; Guo Y; Liu Z
    Chem Biol Interact; 2023 Jan; 369():110294. PubMed ID: 36460127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Mechanism for Nicotinamide Phosphoribosyltransferase Inhibition of TNF-α-mediated Apoptosis in Human Lung Endothelial Cells.
    Oita RC; Camp SM; Ma W; Ceco E; Harbeck M; Singleton P; Messana J; Sun X; Wang T; Garcia JGN
    Am J Respir Cell Mol Biol; 2018 Jul; 59(1):36-44. PubMed ID: 29337590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nampt/PBEF/visfatin and cancer.
    Bi TQ; Che XM
    Cancer Biol Ther; 2010 Jul; 10(2):119-25. PubMed ID: 20647743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fluorometric assay for high-throughput screening targeting nicotinamide phosphoribosyltransferase.
    Zhang RY; Qin Y; Lv XQ; Wang P; Xu TY; Zhang L; Miao CY
    Anal Biochem; 2011 May; 412(1):18-25. PubMed ID: 21211508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice.
    Nencioni A; da Silva RF; Fraga-Silva RA; Steffens S; Fabre M; Bauer I; Caffa I; Magnone M; Sociali G; Quercioli A; Pelli G; Lenglet S; Galan K; Burger F; Vázquez Calvo S; Bertolotto M; Bruzzone S; Ballestrero A; Patrone F; Dallegri F; Santos RA; Stergiopulos N; Mach F; Vuilleumier N; Montecucco F
    Thromb Haemost; 2014 Feb; 111(2):308-22. PubMed ID: 24196571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of NAMPT markedly enhances plasma-activated medium-induced cell death in human breast cancer MDA-MB-231 cells.
    Nagaya M; Hara H; Kamiya T; Adachi T
    Arch Biochem Biophys; 2019 Nov; 676():108155. PubMed ID: 31628926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death.
    Velma GR; Krider IS; Alves ETM; Courey JM; Laham MS; Thatcher GRJ
    J Med Chem; 2024 Apr; 67(8):5999-6026. PubMed ID: 38580317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.